Dosidal · United States

us:authorisation:ANDA209010

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketUnited States
Recordus:authorisation:ANDA209010 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersfda-application: ANDA209010
Source authorityU.S. Food and Drug Administration
Read date
authorisation statusapplication_number: ANDA209010
original_approval: 2018-12-03
products: brand_name: AMLODIPINE AND OLMESARTAN MEDOXOMIL
dosage_form: TABLET
marketing_status: Prescription
product_number: 003
route: ORAL; brand_name: AMLODIPINE AND OLMESARTAN MEDOXOMIL
dosage_form: TABLET
marketing_status: Prescription
product_number: 001
route: ORAL; brand_name: AMLODIPINE AND OLMESARTAN MEDOXOMIL
dosage_form: TABLET
marketing_status: Prescription
product_number: 004
route: ORAL; brand_name: AMLODIPINE AND OLMESARTAN MEDOXOMIL
dosage_form: TABLET
marketing_status: Prescription
product_number: 002
route: ORAL
state: current · read 2026-11-15T11:42:22Z · source: U.S. Food and Drug Administration page
authorised channel
state: unknown
identityapplicant: SCIEGEN PHARMS
application_number: ANDA209010
labelers: Amneal Pharmaceuticals NY LLC; AvKARE; ScieGen Pharmaceuticals, Inc
state: current · read 2026-11-15T11:42:22Z · source: U.S. Food and Drug Administration page
label reference
state: unknown
prescription classmarketing_status_terms: Prescription
state: current · read 2026-11-15T11:42:22Z · source: U.S. Food and Drug Administration page
recalls and notices
state: current · read 2026-11-15T11:42:25Z · source: U.S. Food and Drug Administration page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
0LJOFKt_FcQcDiZaVbftheumaodJVQ7zHnUbCkzc-W7V4klhUNBH-VLbOVR-n7Olpb5FYb_wat0ritNZjJDMeA
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

Dosidal